Movement Alert｜Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings

Market Focus07-24

On July 24, Tempus AI fell 5.26% in regular trading, trading at $43.76/share, with turnover of $80.24 million.

On the news front, multiple headwinds converged to pressure the stock. The company is set to report Q2 earnings on July 30, with consensus expecting revenue of approximately $380 million, representing a deceleration from 36.12% year-over-year growth last quarter to 27.92%, while adjusted EPS is expected at -$0.14. Pre-earnings uncertainty suppressed risk appetite. Additionally, Tempus AI announced a $1.5 billion all-stock acquisition of Personalis at $16.25 per share earlier this week, aiming to integrate its NeXT Personal minimal residual disease detection platform into its AI-driven precision oncology system. While Needham affirmed the acquisition valuation as reasonable, market concerns over funding pressure and integration risks persisted.

The broader Life Sciences Tools and Services sector also traded lower, with Thermo Fisher Scientific down 2.43%, West Pharmaceutical down 4.08%, Waters down 2.57%, Danaher down 0.36%, and Medpace down 0.66%, amplifying sector-wide selling pressure on individual names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1175671504?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-24 22:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175671504","market":"us","top_or_hot":-1,"title":"Movement Alert｜Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings","media":"Market Focus","content":"<p><p>On July 24, Tempus AI fell 5.26% in regular trading, trading at $43.76/share, with turnover of $80.24 million.</p><p>On the news front, multiple headwinds converged to pressure the stock. The company is set to report Q2 earnings on July 30, with consensus expecting revenue of approximately $380 million, representing a deceleration from 36.12% year-over-year growth last quarter to 27.92%, while adjusted EPS is expected at -$0.14. Pre-earnings uncertainty suppressed risk appetite. Additionally, Tempus AI announced a $1.5 billion all-stock acquisition of Personalis at $16.25 per share earlier this week, aiming to integrate its NeXT Personal minimal residual disease detection platform into its AI-driven precision oncology system. While Needham affirmed the acquisition valuation as reasonable, market concerns over funding pressure and integration risks persisted.</p><p>The broader Life Sciences Tools and Services sector also traded lower, with Thermo Fisher Scientific down 2.43%, West Pharmaceutical down 4.08%, Waters down 2.57%, Danaher down 0.36%, and Medpace down 0.66%, amplifying sector-wide selling pressure on individual names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Tempus AI Falls 5.26% in Regular Trading, Sector Weakness and Acquisition Uncertainty Weigh Ahead of Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-24 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 24, Tempus AI fell 5.26% in regular trading, trading at $43.76/share, with turnover of $80.24 million.</p><p>On the news front, multiple headwinds converged to pressure the stock. The company is set to report Q2 earnings on July 30, with consensus expecting revenue of approximately $380 million, representing a deceleration from 36.12% year-over-year growth last quarter to 27.92%, while adjusted EPS is expected at -$0.14. Pre-earnings uncertainty suppressed risk appetite. Additionally, Tempus AI announced a $1.5 billion all-stock acquisition of Personalis at $16.25 per share earlier this week, aiming to integrate its NeXT Personal minimal residual disease detection platform into its AI-driven precision oncology system. While Needham affirmed the acquisition valuation as reasonable, market concerns over funding pressure and integration risks persisted.</p><p>The broader Life Sciences Tools and Services sector also traded lower, with Thermo Fisher Scientific down 2.43%, West Pharmaceutical down 4.08%, Waters down 2.57%, Danaher down 0.36%, and Medpace down 0.66%, amplifying sector-wide selling pressure on individual names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1175671504","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175671504","pubTimestamp":1784904472,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 24, Tempus AI fell 5.26% in regular trading, trading at $43.76/share, with turnover of $80.24 million.On the news front, multiple headwinds converged to pressure the stock. The company is set...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"走势警报|Tempus AI 常规交易中下跌 5.26%，行业疲软和收购不确定性给盈利带来压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"On July 24, Tempus AI fell 5.26% in regular trading, trading at $43.76/share, with turnover of $80.24 million.On the news front, multiple headwinds converged to pressure the stock. The company is set to report Q2 earnings on July 30, with consensus expecting revenue of approximately $380 million, representing a deceleration from 36.12% year-over-year growth last quarter to 27.92%, while adjusted EPS is expected at -$0.14. Pre-earnings uncertainty suppressed risk appetite. Additionally, Tempus AI announced a $1.5 billion all-stock acquisition of Personalis at $16.25 per share earlier this week, aiming to integrate its NeXT Personal minimal residual disease detection platform into its AI-driven precision oncology system. While Needham affirmed the acquisition valuation as reasonable, market concerns over funding pressure and integration risks persisted.The broader Life Sciences Tools and Services sector also traded lower, with Thermo Fisher Scientific down 2.43%, West Pharmaceutical down 4.08%, Waters down 2.57%, Danaher down 0.36%, and Medpace down 0.66%, amplifying sector-wide selling pressure on individual names.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1175671504","isCrawlerRequest":true}